Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Court: No Herceptin Biosimilar Tag For Indian Trastuzumabs

Executive Summary

An Indian court appears to have delivered a frontal blow to defendants Biocon and Mylan in a hotly contested case concerning their biosimilar versions of Roche's Herceptin (trastuzumab).


Related Content

Indian Herceptin Biosimilars Case Simmers
Roche Blocks Indian Trastuzumab; Says No Room For ''Uncertainty''
Relief And Rebuke For Biocon In Herceptin Biosimilars Case
Mylan confident on biosim Herceptin in India despite Roche tactics